ADMA Deadline Alert: Levi & Korsinsky Reminds ADMA BIOLOGICS, INC. (ADMA) Investors of Securities Class Action Deadline on August 10, 2026
ADMA Biologics allegedly used channel stuffing to inflate ASCENIV revenues by millions, turning reported 20% growth into an estimated 3% decline, according to a new securities class action. NEW YORK, July 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ADMA Biologics,...
ADMA Biologics allegedly used channel stuffing to inflate ASCENIV revenues by millions, turning reported 20% growth into an estimated 3% decline, according to a new securities class action. NEW YORK, July 22, 2026 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in ADMA Biologics,...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.